Treatment of graft failure with fludarabine (Flu), antithymocyte globulin (ATG) and a second allogeneic stem cell transplantation (SCT).

被引：0
|
作者：
Jabbour, EJ [1 ]
Shahjahan, M [1 ]
Rondon, G [1 ]
Anderlini, P [1 ]
Giralt, S [1 ]
Couriel, DR [1 ]
Champlin, RE [1 ]
Khouri, IF [1 ]
机构：
[1] MD Anderson Canc Ctr, Houston, TX USA
来源：
BLOOD | 2005年 / 106卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
2734
引用
收藏
页码：767A / 767A
页数：1
相关论文
共 50 条
  • [1] Treatment of donor graft failure with nonmyeloablative conditioning of fludarabine, antithymocyte globulin and a second allogeneic hematopoietic transplantation
    Jabbour, E.
    Rondon, G.
    Anderlini, P.
    Giralt, S. A.
    Couriel, D. R.
    Champlin, R. E.
    Khouri, I. F.
    BONE MARROW TRANSPLANTATION, 2007, 40 (05) : 431 - 435
  • [2] Treatment of donor graft failure with nonmyeloablative conditioning of fludarabine, antithymocyte globulin and a second allogeneic hematopoietic transplantation
    E Jabbour
    G Rondon
    P Anderlini
    S A Giralt
    D R Couriel
    R E Champlin
    I F Khouri
    Bone Marrow Transplantation, 2007, 40 : 431 - 435
  • [3] Acute graft versus host disease after nonmyeloablative allogeneic stem cell transplantation with low-dose TBI, fludarabine and antithymocyte globulin (ATG).
    Grosskreutz, CL
    Egan, R
    Scigliano, E
    Fruchtman, SM
    Isola, LM
    BLOOD, 2004, 104 (11) : 354A - 354A
  • [4] Differences of Antithymocyte Globulin (ATG) Side Effects during Allogeneic Stem Cell Transplantation
    Yanez San Segundo, Lucrecia
    Lopez Pereira, Brenda
    Aranzazu Bermudez, Maria
    Insunza, Andres
    Romon, Inigo
    Richard, Carlos
    Conde, Eulogio
    BLOOD, 2015, 126 (23)
  • [5] Antithymocyte globulin (ATG) as intensification of the conditioning regimen in pediatric patients undergoing stem cell transplantation (SCT).
    Yaniv, I
    Stein, J
    Goshen, J
    BONE MARROW TRANSPLANTATION, 1999, 23 : S180 - S180
  • [6] Second allogeneic haematopoietic stem cell transplantation: a treatment for graft failure
    Remberger, M.
    Mattsson, J.
    Olsson, R.
    Ringden, O.
    BONE MARROW TRANSPLANTATION, 2010, 45 : S292 - S292
  • [7] Second allogeneic hematopoietic stem cell transplantation: a treatment for graft failure
    Remberger, Mats
    Mattsson, Jonas
    Olsson, Richard
    Ringden, Olle
    CLINICAL TRANSPLANTATION, 2011, 25 (01) : E68 - E76
  • [8] FLUDARABINE-BASED SECOND TRANSPLANTATION FOR SECONDARY GRAFT FAILURE AFTER FIRST ALLOGENEIC STEM CELL TRANSPLANTATION
    Sun, Y.
    Xu, L.
    Liu, D.
    Liu, K.
    Huang, X.
    BONE MARROW TRANSPLANTATION, 2014, 49 : S263 - S263
  • [9] Acute graft versus host disease after non-myeloablative allogeneic stem cell transplantation (NST) with low-dose TBI, fludarabine and antithymocyte globulin (ATG)
    Grosskreutz, CL
    Scigliano, E
    Fruchtman, SM
    Isola, LM
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2005, 11 (02) : 42 - 42
  • [10] OUTCOME OF SECOND ALLOGENEIC STEM CELL TRANSPLANTATION (SCT) IN PEDIATRIC PATIENTS WITH GRAFT FAILURE OR RECURRENT LEUKEMIA
    Pawlowska, A. B.
    Cheng, J.
    Stiller, T.
    Palmer, J.
    Hafeez, N.
    Rosenthal, J.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2011, 17 (02) : S309 - S309
12345